As per MRFR analysis, the US Cataract Surgery Device Market Size was estimated at 2.11 (USD Billion) in 2023. The US Cataract Surgery Device Market Industry is expected to grow from 2.5(USD Billion) in 2024 to 4.5 (USD Billion) by 2035. The US Cataract Surgery Device Market CAGR (growth rate) is expected to be around 5.489% during the forecast period (2025 - 2035).
The US Cataract Surgery Device Market is experiencing significant growth driven by several key factors. One of the primary market drivers is the increasing prevalence of cataracts among the aging population, as the demographic of individuals aged 65 and older continues to expand in the US. This age group is more susceptible to cataracts, leading to higher demand for surgical interventions and cataract surgery devices.
Additionally, advancements in technology such as the development of femtosecond laser systems and innovative intraocular lenses are changing the landscape of cataract surgery, making procedures safer, more effective, and less invasive. Opportunities are emerging as healthcare providers seek to improve patient outcomes and operational efficiencies. With the rise in outpatient cataract surgeries, there is a growing need for devices that facilitate less invasive procedures and shorter recovery times.
The emphasis on value-based care in the US healthcare system encourages the integration of advanced technologies that can enhance surgical precision and minimize complications. This is an area ripe for development, as patients and surgeons alike seek improved performance and results from cataract surgery devices. Recently, there has been a noticeable trend toward adopting minimally invasive surgical techniques in the US, which aligns with the broader healthcare focus on patient-centered approaches.
Surgeons are increasingly adopting devices that promote quicker recovery and better visual outcomes, driving innovation within the market. Moreover, as patient awareness regarding surgical options increases, demand for high-quality and advanced cataract surgery devices continues to rise. This evolving landscape presents a dynamic environment for stakeholders in the US Cataract Surgery Device Market to innovate and meet the needs of an expanding patient population.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Cataract Surgery Device Market Industry is experiencing significant growth driven by the increasing aging population in the United States. According to the U.S. Census Bureau, by 2030, it is projected that more than 20% of the US population will be aged 65 and older, reaching approximately 73 million individuals. Age is a substantial risk factor for cataracts; approximately 50% of individuals aged 65 to 74 and nearly 70% of those aged 75 and older are affected by cataracts.
This growing demographic will likely lead to a surge in cataract surgeries, subsequently increasing the demand for advanced surgical devices. Organizations like the American Academy of Ophthalmology and the National Eye Institute are actively researching the implications of aging on eye health and establishing standards that will further support advancements in cataract surgery technologies, thus propelling the overall market growth in this space.
The continuous advancements in surgical technologies are another crucial driver for the US Cataract Surgery Device Market Industry. Innovations such as femtosecond laser systems have improved surgical outcomes and reduced recovery times. According to industry reports, the use of these advanced technologies has increased by over 30% in recent years. Leading companies such as Alcon and Bausch + Lomb are investing substantially in Research and Development (R&D) to further innovate cataract surgery devices.
The successful development and adoption of these high-precision surgical devices are critical in improving the efficiency and safety of cataract surgeries, thus meeting the growing demands of the aging population in the US.
The rising prevalence of eye disorders, including cataracts, directly influences the US Cataract Surgery Device Market Industry. Studies indicate that nearly 24.4 million Americans aged 40 and older have cataracts, a figure projected to increase as the population ages. The Centers for Disease Control and Prevention (CDC) highlights that such eye disorders are expected to rise as part of the overall trend of increasing chronic diseases in the US.
This rising prevalence will augment the demand for cataract surgeries and necessitate the production and use of innovative surgical devices. Major players in the market are now focusing on developing devices that address various complications arising from these disorders, ensuring a steady market growth in future years.
The US Cataract Surgery Device Market has demonstrated a significant focus on various Device Types, reflecting the evolving needs of patients and advancements in surgical techniques. The Intraocular Lens (IOL) stands out as a critical component in cataract surgery, offering patients improved vision and quality of life post-surgery. Advancements in IOL technology have enabled the development of multifocal and accommodating lenses, allowing for better correction of presbyopia alongside cataract treatment.
This innovation not only enhances vision at multiple distances but also plays a crucial role in reducing dependence on glasses after surgery. Similarly, the Ophthalmic Viscoelastic Device (OVD) segment is essential for effectively performing cataract surgeries. OVDs help maintain the shape of the anterior chamber during the procedure, thereby protecting both the corneal endothelium and other intraocular structures. The use of viscoelastic agents also facilitates the insertion of the IOL, ensuring smooth surgical operations, which is vital for optimal surgical outcomes and patient satisfaction.
Phacoemulsification Equipment is another key segment in this market. This technology employs ultrasound energy to emulsify the cataractous lens, allowing for its safe and efficient removal. The continual advancement in phacoemulsification techniques contributes to shorter surgery times, minimal surgical trauma, and faster recovery for patients. Such characteristics are particularly attractive in the US market, where patient satisfaction and quick return to daily activities are highly prioritized.
Femtosecond Laser Equipment is emerging as an innovative tool, enhancing the precision of cataract surgery. The utilization of laser technology allows for more accurate incisions and lens fragmentation, reducing risks associated with traditional methods. This groundbreaking approach significantly improves patient outcomes by offering less invasive options, which is becoming a significant selling point in the competitive landscape of ophthalmic surgery devices.
Overall, Device Types such as Intraocular Lenses, Ophthalmic Viscoelastic Devices, Phacoemulsification Equipment, and Femtosecond Laser Equipment are essential for the US Cataract Surgery Device Market. Their developments are driven by a combination of technological advancements, growing patient expectations, and the increasing prevalence of cataracts in the aging population. With an expanding demographic likely to undergo cataract surgery, these segments are well-positioned for growth and innovation in the coming years as they continually adapt to meet the dynamic requirements of the healthcare industry and patient needs.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Cataract Surgery Device Market is shaped significantly by its End Users, including Ophthalmology Centers, Hospitals, and Clinics, each playing a vital role in the ecosystem of cataract care. Ophthalmology Centers are at the forefront, providing specialized services and advanced technologies that cater specifically to eye health issues such as cataracts, thereby driving increased patient flow and enhancing treatment options.
Hospitals offer comprehensive care, often integrating various medical specialties, which allows them to manage more complex cases effectively, contributing to a large volume of surgeries performed annually. Clinics serve as accessible points of care where patients can receive preliminary evaluations and follow-up treatments, thus supporting earlier intervention and streamlined patient pathways. Together, these End Users reflect the US Cataract Surgery Device Market segmentation’s emphasis on tailored care, ensuring patients benefit from technologies that enhance surgical outcomes.
The market growth is further supported by increasing aging populations who are more susceptible to cataracts, alongside advancements in surgical techniques and devices, creating ample opportunities for all segments involved.
The US Cataract Surgery Device Market is characterized by a competitive landscape fueled by technological advancements, an increasing aging population, and a high prevalence of cataract conditions. This market is expected to continue evolving as various players strive to innovate and expand their product offerings. Companies are focusing on developing devices that enhance surgical precision and reduce recovery time, which is essential given the growing demand for cataract surgeries in the United States.
The competitive dynamics are influenced by factors such as pricing strategies, product differentiation, regulatory compliance, and effective marketing strategies. As competitors vie for market share, collaboration, partnerships, and strategic alliances are becoming increasingly important to maintain an edge in this lucrative sector.
Santen Pharmaceutical has a notable presence in the US Cataract Surgery Device Market, recognized for its commitment to developing high-quality ophthalmic products. The company's strengths lie in its extensive research and development capabilities, allowing it to deliver innovative solutions tailored to the needs of patients and healthcare professionals. With a pipeline focused on various ocular conditions, including cataracts, Santen Pharmaceutical aims to leverage its expertise in cataract technology to enhance surgical outcomes.
The company's strategic initiatives also play a vital role in establishing strong relationships within the healthcare ecosystem, positioning it as a reliable partner in the market. Santen's focus on customer engagement and extensive distribution networks further strengthens its competitive position, making it a key player in the US marketplace.
Nidek is another significant contender in the US Cataract Surgery Device Market, known for its diverse range of ophthalmic equipment and its commitment to enhancing visual health. Offering products such as phacoemulsification systems and optical coherence tomography, Nidek has established a comprehensive portfolio that meets the varying demands of cataract surgeons. The company's strengths include advanced technology and consistent quality, which have earned it a reputation among clinicians in the region.
Additionally, Nidek’s approach to mergers and acquisitions has allowed it to strengthen its market presence and expand its capabilities, fostering innovation in surgical devices. With ongoing investments in research and development, Nidek aims to maintain leadership within the industry while catering to the evolving needs of eye care professionals throughout the United States.
The US Cataract Surgery Device Market has recently seen significant advancements with companies such as Alcon and Johnson and Johnson continuing to lead in innovation. In October 2023, Alcon announced the launch of its latest intraocular lens technology, aiming to enhance surgical outcomes and patient satisfaction. Meanwhile, Johnson and Johnson's Vision segment has been focusing on expanding its portfolio through strategic collaborations.
In terms of mergers and acquisitions, Kowa Company acquired a minority stake in Rayner Surgical in September 2023, aiming to enhance its presence in the advanced ocular device segment. Additionally, Bausch + Lomb has been expanding its offerings by investing in Research and Development for next-generation surgical devices. The market valuation is projected to grow significantly due to the rising prevalence of cataract surgeries, with an increasing number of older adults seeking treatment.
This growth has led to heightened competition among key players including Abbott Laboratories, Hoya Corporation, and Staar Surgical. Over the past two years, the market has also adapted to regulatory changes by the US Food and Drug Administration, focusing on safer and more efficient surgical devices, which underscores the dynamic nature of the industry.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 2.11(USD Billion) |
| MARKET SIZE 2024 | 2.5(USD Billion) |
| MARKET SIZE 2035 | 4.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.489% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Santen Pharmaceutical, Nidek, Iridex Corporation, Abbott Laboratories, Hoya Corporation, Ocular Therapeutix, Rayner Surgical, Carl Zeiss AG, Alcon, Staar Surgical, Bausch + Lomb, Kowa Company, Johnson and Johnson, BVI, Lumia Medical |
| SEGMENTS COVERED | Device Type, End Users |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Increased prevalence of cataracts, Rising geriatric population, Growth in outpatient surgeries, Enhanced surgical precision and outcomes |
| KEY MARKET DYNAMICS | Increasing aging population, Rising prevalence of cataracts, Technological advancements in devices, Growing awareness of eye health, Rising healthcare expenditure |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Cataract Surgery Device Market is expected to be valued at 2.5 billion USD in 2024.
By 2035, the US Cataract Surgery Device Market is projected to reach a value of 4.5 billion USD.
The market is anticipated to grow at a CAGR of 5.489 percent from 2025 to 2035.
In 2024, the Intraocular lens (IOL) segment is expected to dominate the market, valued at 1.0 billion USD.
By 2035, the Intraocular lens (IOL) segment is projected to grow to 2.0 billion USD.
Major players in the market include Abbott Laboratories, Alcon, and Johnson & Johnson among others.
The Ophthalmic Viscoelastic Device (OVD) segment is expected to reach 1.0 billion USD by 2035.
The market faces challenges including regulatory hurdles and potential shortages of key materials.
The Phacoemulsification Equipment segment is forecasted to grow to 1.3 billion USD by 2035.
There are significant opportunities for growth due to technological advancements and an increasing aging population.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
